yi-rong Zheng

Dr. yi-rong Zheng


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2021 in Frontiers in Pediatrics
Verified
Journal Article
Open access
HWHong-Lin Wu
Hong-Lin Wu
YLYu-Qing Lei
Yu-Qing Lei
WXWen-Peng Xie
Wen-Peng Xie
QCqiang chen
qiang chen
YZyi-rong Zheng
yi-rong Zheng
Objective: This study aimed to evaluate the effects of nasal high-frequency oscillatory ventilation (NHFOV) vs. nasal continuous positive airway pressure (NCPAP) on postextubation respiratory failure (PRF) in infants after congenital heart surgery (CHS).Method: Eighty infants underwent postoperative invasive mechanical ventilation for more than 12 h and planned extubation. The infants were randomized to undergo either NHFOV or NCPAP after extubation. Primary outcomes were the incidence of PRF and reintubation, the average PaCO2 level, the average oxygenation index (OI), and pulmonary recruitment in the early extubation phase. Secondary outcomes included the NCPAP/NHFOV time, length of hospital stay, treatment intolerance, signs of discomfort, pneumothorax, adverse hemodynamic effects, nasal trauma, and mortality.Results: Except for PaCO2 within 12 after extubation (39.3 ± 5.8 vs. 43.6 ± 7.3 mmHg, p = 0.05), there was no statistically significant difference for any of the primary outcome measure (PRF, reintubation within 12 h after extubation, oxygenation index within 12 h after extubation, or lung volumes on X-ray after extubation) or secondary outcome measures (duration of non-invasive ventilation, duration of hospital stay, ventilation intolerance, signs of discomfort, pneumothorax, nasal trauma, adverse hemodynamic effects, or death prior to discharge), p > 0.1 for each comparison.Conclusion: NHFOV therapy after extubation in infants after CHS was more efficient in improving CO2 cleaning than NCPAP therapy, but there was no difference in other outcomes (PRF, reintubation, oxygenation index, and pulmonary recruitment).

8 May 2021 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
YZyi-rong Zheng
yi-rong Zheng
WXWen‐Peng Xie
Wen‐Peng Xie
JLJian‐Feng Liu
Jian‐Feng Liu
HWHong‐Lin Wu
Hong‐Lin Wu
NXNing Xu
Ning Xu
QCqiang chen
qiang chen

11 January 2022 in Frontiers in Pediatrics
Verified
Journal Article
Open access
SLShuhua Lai
Shuhua Lai
YXYing-Ling Xie
Ying-Ling Xie
ZCZhi-Qing Chen
Zhi-Qing Chen
RCRong Chen
Rong Chen
WCWen-Hong Cai
Wen-Hong Cai
YZyi-rong Zheng
yi-rong Zheng
Objectives: The aim of this study was to investigate the safety and feasibility of nHFOV as initial respiratory support in preterm infants with RDS.Methods: This study retrospectively analyzed the clinical data of 244 premature infants with RDS who were treated in our hospital from January 2016 to January 2019 and divided into the nHFOV group (n = 115) and the BiPAP group (n = 129) based on the initial respiratory support method.Results: Respiratory outcomes showed that the rate of NIV failure during the first 72 hours of life in the nHFOV group was significantly lower than that in the BiPAP group. The time of NIV in the nHFOV group was significantly shorter than that in the BiPAP group. The time of supplemental oxygen in the nHFOV group was significantly shorter than that in the BiPAP group. The incidence of air leakage syndrome in the nHFOV group was significantly lower than that in the BiPAP group, and the length of hospital stay of the nHFOV group was also significantly shorter than that in the BiPAP group. Although the rate of infants diagnosed with BPD was similar between the two groups, the rate of severe BPD in the nHFOV group was significantly lower than that in the BiPAP group.Conclusion: This study showed that nHFOV as initial respiratory support for preterm infants with RDS was feasible and safe compared to BiPAP. Furthermore, nHFOV can reduce the need for IMV and reduce the incidence of severe BPD and air leak syndrome.


27 June 2022 in Frontiers in Pediatrics
Verified
Journal Article
Open access
YLYun-Feng Lin
Yun-Feng Lin
WLWen-Hao Lin
Wen-Hao Lin
SLShi-Hao Lin
Shi-Hao Lin
QZQi-Liang Zhang
Qi-Liang Zhang
QCqiang chen
qiang chen
YZyi-rong Zheng
yi-rong Zheng
Objective: To explore the effects of human milk fortifier (HMF) on improving the preoperative nutritional status of infants with non-restricted ventricular septal defect (VSD).Methods: A prospective randomized controlled study was conducted in a provincial hospital in China. Participants were randomly divided into an intervention group (n = 29) and a control group (n = 29). HMFs were added proportionally to the infants' feeds in the intervention group based on breastfeeding status, and the infants in the control group received exclusive breastfeeding as needed. The nutritional status of the two groups was compared 1 month after the intervention.Results: Compared with the control group, the weight, head circumference, height, albumin level, and prealbumin level of the human milk fortifier group were significantly higher 1 month after the intervention (p < 0.05). The STRONGkids score of the HMF group was significantly lower than that of the non-HMF group (p < 0.05). There was no significant difference in pneumonia, liver insufficiency, feeding intolerance, or jaundice between the two groups.Conclusion: The addition of HMFs based on the breastfeeding status of infants with non-restricted VSD can improve the preoperative nutritional status and does not increase the incidence of gastrointestinal complications.Clinical Trial Registration: http://www.chictr.org.cn/index.aspx, identifier: ChiCTR2000041135.

1 July 2022 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
PDF file
HWHong-Lin Wu
Hong-Lin Wu
YLYu-Qing Lei
Yu-Qing Lei
WLWen-Hao Lin
Wen-Hao Lin
SHShu-Ting Huang
Shu-Ting Huang
QCqiang chen
qiang chen
YZyi-rong Zheng
yi-rong Zheng